EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The impact of acyl-CoA:cholesterol transferase (ACAT) inhibitors on biophysical membrane properties depends on membrane lipid composition

Huong To, Peter Reinholdt, Mohammad Bashawat, Meike Luck, Line Lauritsen, Vibeke Akkerman, Matthias Kroiss, Daniel Wüstner, Jacob Kongsted, Peter Müller, Holger A Scheidt

Molecular and Cellular Endocrinology · 2024

DOI: 10.1016/j.mce.2024.112385 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular and Cellular Endocrinology, 2024. Verfasst von Huong To und 10 weiteren Autor:innen. Beteiligte Einrichtung: Humboldt University Berlin, Department of Biology, Invalidenstr. 42, 10115, Berlin, Germany. Hauptthemen laut MEDLINE: Sterol O-Acyltransferase, Membrane Lipids, Enzyme Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: German Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acyl-coenzyme A: cholesterol acyltransferases are enzymes which are involved in the homeostasis of cholesterol. Impaired enzyme activity is associated with the occurrence of various diseases like Alzheimer's disease, atherosclerosis, and cancers. At present, mitotane is the only inhibitor of this class of enzymes in clinical use for the treatment of adrenocortical carcinoma but associated with common and severe adverse effects. The therapeutic effect of mitotane depends on its interaction with cellular membranes. The search for less toxic but equally effective compounds is hampered by an incomplete understanding of these biophysical properties. In the present study, the interaction of the three ACAT inhibitors nevanimibe, Sandoz 58-035, and AZD 3988 with membranes has been investigated using lipid model membranes in conjunction with biophysical experimental (NMR, ESR, fluorescence) and theoretical (MD simulations) approaches. The data show, that the drugs (i) incorporate into lipid membranes, (ii) differently influence the structure of lipid membranes; (iii) affect membrane structure depending on the lipid composition; and (iv) do not cause hemolysis of red blood cells. The results are discussed with regard to the use of the drugs, in particular to better understand their efficacy and possible side effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sterol O-AcyltransferaseMembrane LipidsEnzyme InhibitorsHumansMolecular Dynamics SimulationCell MembraneBenzimidazolesHemolysisLipid BilayersErythrocytesAcetamidesSulfonamides

Stichwörter der Autor:innen

AZD 3988Acyl-coenzyme AAcyl-coenzyme A:cholesterol O-AcyltransferaseDiacylglycerol O-AcyltransferasesLipid membraneLipid-drug interactionNevanimibeSandoz 58-035Sterol-O-acyl transferases

Substanzen

Sterol O-AcyltransferaseMembrane LipidsEnzyme InhibitorsavasimibeBenzimidazolesLipid BilayersAcetamidesSulfonamides

Autor:innen und Institutionen

  • Humboldt University Berlin, Department of Biology, Invalidenstr. 42, 10115, Berlin, Germany.
  • Department of Physics, Chemistry and Pharmacy, University of Southern Denmark, DK-5230, Odense M, Denmark.
  • Department of Biochemistry and Molecular Biology, University of Southern Denmark, DK-5230, Odense M, Denmark.
  • LMU University Hospital, LMU Munich, Department of Internal Medicine IV, Ziemssenstr. 5, 80336, München, Germany.
  • Humboldt University Berlin, Department of Biology, Invalidenstr. 42, 10115, Berlin, Germany. Electronic address: peter.mueller.3@rz.hu-berlin.de.
  • Leipzig University, Institute for Medical Physics and Biophysics, Härtelstr. 16-18, 04107, Leipzig, Germany. Electronic address: holger.scheidt@medizin.uni-leipzig.de.

Förderung

  • German Research Foundation

Zitieren

APA

To, H., Reinholdt, P., Bashawat, M., Luck, M., Lauritsen, L., Akkerman, V., Kroiss, M., Wüstner, D., Kongsted, J., Müller, P., & Scheidt, H. A. (2024). The impact of acyl-CoA:cholesterol transferase (ACAT) inhibitors on biophysical membrane properties depends on membrane lipid composition. Molecular and Cellular Endocrinology. https://doi.org/10.1016/j.mce.2024.112385

Vancouver

To H, Reinholdt P, Bashawat M, Luck M, Lauritsen L, Akkerman V, et al. The impact of acyl-CoA:cholesterol transferase (ACAT) inhibitors on biophysical membrane properties depends on membrane lipid composition. Molecular and Cellular Endocrinology. 2024. doi:10.1016/j.mce.2024.112385

BibTeX
@article{To2024,
  author = {To, Huong and Reinholdt, Peter and Bashawat, Mohammad and Luck, Meike and Lauritsen, Line and Akkerman, Vibeke and Kroiss, Matthias and Wüstner, Daniel and Kongsted, Jacob and Müller, Peter and Scheidt, Holger A},
  title = {The impact of acyl-CoA:cholesterol transferase (ACAT) inhibitors on biophysical membrane properties depends on membrane lipid composition},
  journal = {Molecular and Cellular Endocrinology},
  year = {2024},
  doi = {10.1016/j.mce.2024.112385}
}
Kostenlos starten →